Media headlines about Fonar (NASDAQ:FONR) have been trending somewhat positive on Saturday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Fonar earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave news articles about the medical equipment provider an impact score of 46.9417649480488 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Fonar (NASDAQ:FONR) opened at $24.00 on Friday. The company has a market cap of $160.08, a PE ratio of 8.70 and a beta of 2.71. Fonar has a 52 week low of $17.20 and a 52 week high of $33.90.
ILLEGAL ACTIVITY WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Fonar (FONR) Share Price” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://ledgergazette.com/2018/01/13/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-fonar-fonr-stock-price.html.
Fonar Company Profile
Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: Medical Equipment segment, and Physician Management and Diagnostic Services segment.
Receive News & Ratings for Fonar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fonar and related companies with MarketBeat.com's FREE daily email newsletter.